Go-to-Info | Information Bulletins

“Go-to-Info” is the short name for HIPAA Administrative Simplification Information Bulletins. Informational Bulletins share information, address operational and technical issues, and highlight best practices, initiatives or related efforts. Informational Bulletins do not establish new policy or provide new guidance.
Information Bulletins


Announces the publication of the final rule CMS-0055-F, which modifies the requirements for use of the National Council for Prescription Drug Programs (NCPDP) Telecommunication Standard Implementation Guide, Version D, Release 0, August 2007, by requiring the use of the Quantity Prescribed (460-ET) field to identify partial fills for Schedule II drugs.

Announces the release of revised statistical reports regarding the CMS HIPAA complaint enforcement program.

Announces the publication of Final Rule CMS-0054-F, which eliminates the regulatory requirement for health plans to obtain and use an HPID and eliminates the voluntary acquisition and use of the OEID.

Announces the launch of the volunteer Program Pilot Program to test the process for reviewing compliance with HIPAA Administrative Simplification rules among providers.

Announces the launch of the Compliance Review Program to ensure compliance among covered entities with HIPAA Administrative Simplification rules for electronic health care transactions.

Announces the completion of the Optimization Pilot, a small-scale effort to recruit volunteer health plans and clearinghouses to submit HIPAA standard transactions to HHS for compliance testing. HHS initiated the Optimization Pilot in preparation for the full-scale Compliance Review Program.

Announces the publication of a proposed rule to modify the requirements for the use of the Telecommunication Standard Implementation Guide, Version D, Release 0 (Version D.0), August 2007, National Council for Prescription Drug Programs (NCPDP) by requiring HIPAA covered entities to use the Quantity Prescribed field (460-ET) for retail pharmacy transactions for Schedule II drugs.

Announces the publication of a proposed rule to eliminate the regulatory requirement for health plans to obtain and use an HPID, as well as eliminate the voluntary acquisition and use of the OEID.

Provides an overview of Subregulatory Guidance materials.
Feedback
NSG has created a special mailbox to receive questions, comments and feedback on Guidance Letters, Bulletins, and FAQs, and any other related matters. The address for that mailbox is AdministrativeSimplification@cms.hhs.gov.
Keep Up to Date!
Sign up for Administrative Simplification Email Updates and follow us on Twitter